Cargando…
The relationship between sclerostin and carotid artery atherosclerosis in patients with stage 3–5 chronic kidney disease
PURPOSE: Sclerostin is an antagonist of the Wnt/β-catenin pathway. We previously reported that sclerostin is closely related to carotid artery atherosclerosis and long-term outcome in hemodialysis patients. The present study investigated the association between sclerostin, renal function, and caroti...
Autores principales: | Zhao, Ban, Chen, Aiqun, Wang, Haitao, Cui, Ju, Sun, Ying, Xu, Lengnan, Mao, Yonghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314717/ https://www.ncbi.nlm.nih.gov/pubmed/32458213 http://dx.doi.org/10.1007/s11255-020-02495-x |
Ejemplares similares
-
Associations of sclerostin with carotid artery atherosclerosis and all-cause mortality in Chinese patients undergoing maintenance hemodialysis
por: Chen, Aiqun, et al.
Publicado: (2018) -
Frailty in Patients With Chronic Kidney Disease Stage Five
por: Joseph, Jerry, et al.
Publicado: (2023) -
Tripterygium wilfordii Hook F Treatment for Stage IV Diabetic Nephropathy: Protocol for a Prospective, Randomized Controlled Trial
por: Lengnan, Xu, et al.
Publicado: (2020) -
The risk of atherosclerosis in patients with chronic kidney disease
por: Olechnowicz-Tietz, Sylwia, et al.
Publicado: (2013) -
Effect of telmisartan on kidney function in patients with chronic kidney disease: an observational study
por: Agrawal, Ashish, et al.
Publicado: (2016)